CareDx, Inc.
For the period ended Dec 31, 2025. Filed Feb 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 25, 2026
CDNA$80.77-4.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
(a)(1) Financial Statements:
Our Consolidated Financial Statements are listed in the “Index to Consolidated Financial Statements” of CareDx, Inc. Part II, Item 8 of this Annual Report on Form 10-K.
(a)(2) Financial Statement Schedules
All financial statement schedules have been omitted because they are not required, not applicable, or the required information is included in the consolidated financial statements or notes thereto included in this Annual Report on Form 10-K.
(a)(3) Exhibits
The following exhibits are incorporated by reference or are filed with this report, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).
| ExhibitNumber · Incorporated by Reference | |||||
|---|---|---|---|---|---|
| Description · Form · File No. · Exhibit · Filing Date | |||||
| 3.1 | Amended and Restated Certificate of Incorporation of the Registrant. | 10-Q | 001-36536 | 3.1 | 8/28/2014 |
| 3.2 | Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Registrant, filed June 17, 2021. | 8-K | 001-36536 | 3.1 | 6/21/2021 |
| 3.3 | Certificate of Amendment to the Amended and Restated Certificate of Incorporation, dated June 16, 2023. | 8-K | 001-36536 | 3.1 | 6/20/2023 |
| 3.4 | Amended and Restated Bylaws of the Registrant, effective as of December 12, 2025. | 8-K | 001-36536 | 3.1 | 12/15/2025 |
| 4.1 | Form of Registrant’s common stock certificate. | 10-K | 001-36536 | 4.1 | 3/31/2015 |
| 4.2# | 2014 Equity Incentive Plan, as amended. | 10-Q | 001-36536 | 4.2 | 7/29/2021 |
| 4.3# | Form of Option Agreement under the 2014 Equity Incentive Plan for New Options. | SC TO-I | 005-88252 | 99(d)(3) | 10/12/2017 |
| 4.4# | 2014 Employee Stock Purchase Plan and forms of agreements thereunder. | S-8 | 333-197493 | 4.5 | 7/18/2014 |
| 4.5# | 2016 Inducement Equity Incentive Plan. | 10-Q | 333-211538 | 4.5 | 7/29/2021 |
| 4.6# | 2019 Inducement Equity Incentive Plan. | 10-Q | 001-36536 | 4.7 | 7/29/2021 |
| 4.7 | Description of Securities of the Registrant | 10-K | 001-36536 | 4.7 | 2/28/2025 |
| 4.8# | Amendment No. 1 to the CareDx, Inc. 2024 Equity Incentive Plan. | 8-K | 001-36536 | 10.1 | 6/12/2025 |
| 10.1#* | Form of Change of Control and Severance Agreement between the Registrant and each of its executive officers. | ||||
| 10.2# | Form of Indemnification Agreement between the Registrant and each of its directors and executive officers. | S-1 | 333-196494 | 10.1 | 6/3/2014 |
| 10.3# | Executive Incentive Compensation Plan. | 10-K | 001-36536 | 10.19 | 3/31/2015 |
| 10.4 | Lease, dated April 27, 2006, as amended on November 10, 2010, by and between the Registrant and BMR-Bayshore Boulevard LLC, for office and laboratory space located at 3260 Bayshore Boulevard, Brisbane, California 94005. | S-1 | 333-196494 | 10.12 | 6/3/2014 |
| 10.5+ | Second Amendment to Lease, dated January 2, 2020, by and between the Registrant and BMR-Bayshore Boulevard LP (formerly known as BMR-Bayshore Boulevard LLC), for office and laboratory space located at 3260 Bayshore Boulevard, Brisbane, California 94005. | 10-Q | 001-36536 | 10.1 | 4/30/2020 |
| 10.6+ | Third Amendment to Lease, dated June 27, 2022, by and between the Registrant and BMR-Bayshore Boulevard LP. | 10-Q | 001-36536 | 10.2 | 11/3/2022 |
| ExhibitNumber · Incorporated by Reference | |||||
|---|---|---|---|---|---|
| ExhibitNumber | Description | Form | File No. | Exhibit | Filing Date |
| 10.7+ | Lease, dated June 14, 2022, by and between the Registrant and HCP Life Science REIT, Inc. | 10-Q | 001-36536 | 10.4 | 8/14/2022 |
| 10.8+ | Lease, dated February 28, 2022, by and between the Registrant and One Miracle Place, LLC. | 10-Q | 001-36536 | 10.1 | 11/3/2022 |
| 10.9† | License and Commercialization Agreement, dated May 4, 2018, by and between the Registrant and Illumina, Inc. | 10-Q/A | 001-36536 | 10.3 | 10/9/2018 |
| 10.10 | Sales Agreement, dated April 14, 2022, by and between the Registrant and Jefferies LLC. | 8-K | 001-36536 | 1.1 | 4/15/2022 |
| 10.11+# | Retention Bonus Letter, dated December 1, 2023, by and between the Registrant and Abhishek Jain. | 10-K | 001-36536 | 10.19 | 2/28/2024 |
| 10.12# | Offer Letter, dated March 24, 2024, between the Registrant and John Hanna. | 8-K | 001-36536 | 10.1 | 4/16/2024 |
| 10.13# | Change of Control and Severance Agreement, dated March 25, 2024, between the Registrant and John Hanna. | 8-K | 001-36536 | 10.2 | 4/16/2024 |
| 10.14# | Confidential Information, Invention Assignment, Non-Competition, and Arbitration Agreement, dated March 24, 2024, between the Registrant and John Hanna. | 8-K | 001-36536 | 10.3 | 4/16/2024 |
| 10.15# | CareDx, Inc. 2024 Equity Incentive Plan. | 8-K | 001-36536 | 10.1 | 6/18/2024 |
| 10.16# | Offer Letter, dated July 27, 2024, between the Registrant and Keith Kennedy. | 8-K | 001-36536 | 10.1 | 9/12/2024 |
| 10.17# | Change of Control and Severance Agreement, dated July 27, 2024, between the Registrant and Keith Kennedy. | 8-K | 001-36536 | 10.2 | 9/12/2024 |
| 10.18# | Confidential Information, Invention Assignment, Non-Competition, and Arbitration Agreement, dated July 27, 2024, between the Registrant and Keith Kennedy. | 8-K | 001-36536 | 10.3 | 9/12/2024 |
| 10.19# | Inducement Restricted Stock Unit Agreement, effective as of September 12, 2024, by and between the Registrant and Keith Kennedy. | 10-Q | 001-36536 | 10.4 | 11/4/2023 |
| 10.20# | Inducement Stock Option Agreement, effective as of September 12, 2024, by and between the Registrant and Keith Kennedy. | 10-Q | 001-36536 | 10.5 | 11/4/2024 |
| 10.21# | Offer Letter, dated August 30, 2024, by and between the Registrant and Jessica Meng. | 10-Q | 001-36536 | 10.6 | 11/4/2024 |
| 10.22# | Change of Control and Severance Agreement, dated August 30, 2024, by and between the Registrant and Jessica Meng. | 10-Q | 001-36536 | 10.7 | 11/4/2024 |
| 10.23# | Confidential Information, Invention Assignment, Non-Competition, and Arbitration Agreement, dated August 30, 2024, by and between the Registrant and Jessica Meng. | 10-Q | 001-36536 | 10.8 | 11/4/2024 |
| 10.24# | Inducement Restricted Stock Unit Agreement, effective as of September 12, 2024, by and between the Registrant and Jessica Meng. | 10-Q | 001-36536 | 10.9 | 11/4/2024 |
| 10.25# | Inducement Stock Option Agreement, effective as of September 12, 2024, by and between the Registrant and Jessica Meng. | 10-Q | 001-36536 | 10.10 | 11/4/2024 |
| 10.26# | Care Dx, Inc. 2025 Inducement Equity Incentive Plan and the forms of award agreements thereunder. | S-8 | 333-291254 | 99.3 | 11/4/2025 |
| 10.27 | Outside Director Compensation Policy, as amended and restated June 13, 2025 | 10-Q | 001-36536 | 10.2 | 8/6/2025 |
| 10.28# | Change of Control and Severance Agreement, dated March 27, 2025, between CareDx, Inc. and Abhishek Jain. | 8-K | 001-36536 | 10.1 | 3/28/2025 |
| ExhibitNumber · Incorporated by Reference | |||||
|---|---|---|---|---|---|
| ExhibitNumber | Description | Form | File No. | Exhibit | Filing Date |
| 10.29# | CareDx, Inc. Amended and Restated Outside Director Compensation Policy, as amended and restated effective June 13, 2025. | 10-Q | 001-36536 | 10.2 | 8/6/2025 |
| 10.30# | Offer Letter, dated May 20, 2025, between CareDx, Inc. and Nathan Smith. | 10-Q | 001-36536 | 10.3 | 8/6/2025 |
| 10.31# | Change of Control and Severance Agreement, dated May 20, 2025, between CareDx, Inc. and Nathan Smith. | 10-Q | 001-36536 | 10.4 | 8/6/2025 |
| 10.32# | Confidential Information, Invention Assignment, Non-Competition, and Arbitration Agreement, dated May 20, 2025, between CareDx, Inc. and Nathan Smith. | 10-Q | 001-36536 | 10.5 | 8/6/2025 |
| 10.33# | Release of Claims Agreement, dated August 6, 2025, between CareDx, Inc. and Abhishek Jain. | 10-Q | 001-36536 | 10.1 | 11/4/2025 |
| 10.34# | Consulting Agreement, dated August 6, 2025, between CareDx, Inc. and Abhishek Jain. | 10-Q | 001-36536 | 10.2 | 11/4/2025 |
| 10.35#* | Offer Letter, dated October 6, 2021, between CareDx, Inc. and Jeffrey Novack. | ||||
| 10.36#* | Change of Control and Severance Agreement, dated March 26, 2025, between CareDx, Inc. and Jeffrey Novack. | ||||
| 10.37#* | Confidential Information, Invention Assignment, Non-Competition, and Arbitration Agreement, dated October 6, 2021, between CareDx, Inc. and Jeffrey Novack. | ||||
| 19.1* | Insider Trading Policy and Guidelines with Respect to Certain Transactions in Company Securities. | ||||
| 21.1* | Subsidiaries of the Registrant. | ||||
| 23.1* | Consent of Deloitte & Touche LLP, Independent Registered Public Accounting Firm. | ||||
| 24.1* | Power of Attorney (included on the signature page of this Annual Report on Form 10-K). | ||||
| 31.1* | Principal Executive Officer’s Certifications Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 31.2* | Principal Financial Officer’s Certifications Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.1** | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. § 1350 (Section 906 of Sarbanes-Oxley Act of 2002). | ||||
| 97 | CareDx, Inc. Clawback Policy | 10-K | 001-36536 | 97 | 2/28/2024 |
| 101.INS* | Inline XBRL Instance Document | ||||
| 101.SCH* | Inline XBRL Taxonomy Extension Schema | ||||
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase | ||||
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase | ||||
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase | ||||
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase | ||||
| 104 | Cover Page Interactive Data File, formatted in Inline XBRL | ||||
† Confidential treatment has been granted with respect to certain portions of this Exhibit. Omitted portions have been filed separately with the SEC.
+Non-material schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Registrant hereby undertakes to furnish supplementally copies of any of the omitted schedules and exhibits upon request by the SEC.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.